List No. 404: New Names

The following nonproprietary names for the compounds described have been adopted by the United States Adopted Names (USAN) Council, which is sponsored by the American Medical Association, the American Pharmaceutical Association, and the U.S. Pharmacopeial Convention, Inc., in cooperation with the respective pharmaceutical manufacturers. The designation USAN (United States Adopted Name) distinguishes these formally adopted nonproprietary names from other names. The information given under the category Therapeutic Claim is based on the manufacturer's claims at the time of publication. Adoption of USAN does not imply endorsement of the claims or products by the AMA, the U.S. Pharmacopeia, or the APhA. In some instances, the drugs listed are available only from the manufacturer to properly qualified investigators for clinical study. Reprints of the USAN Council New Names Column are available at no charge by contacting the United States Adopted Names Council, American Medical Association, 5 15 North State Street, Chicago, IL 60610, (312)464‐4056. Clinical Pharmacology and Therapeutics (1998) 63, 604–606; doi: 10.1038/clpt.1998.58